Navigation Links
Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
Date:11/21/2008

er major companies.

Based on our transforming scientific discoveries and sound business model, Intellect is on track to become a major player in the discovery and development of drugs to treat AD, a devastating disease that is rapidly growing in prevalence and for which there are currently no efficacious disease-modifying treatments. We have made excellent progress towards achieving our goal for our company even in the face of a truly daunting financial market.

Financially, we continue to vigorously pursue various options to provide the funding necessary to fully realize the aforementioned strategy. We thank you for your patience and understanding as we go through this process.

As we move forward to realize the potential of our discoveries, we are grateful for the support and confidence of all of our shareholders. Be assured that we are steadfast in the pursuit of our goal to build a company that makes significant contributions to the public health and that brings outstanding financial rewards to its investors.

Thank you for your continued interest and support of Intellect Neurosciences, as we work to develop new drugs aimed at slowing or preventing Alzheimer's disease.

Sincerely,

Daniel Chain, Ph.D.

About Intellect Neurosciences, Inc.

Intellect Neurosciences, Inc. is a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of AD and other disorders. The Company has a broad proprietary immunotherapy platform for both passive and active immunization against AD. Also, Intellect has completed Phase I clinical trials for OXIGON(R), which has the potential to be used as a treatment for AD and other serious disorders.

For additional information, please visit
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
4. Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
5. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
6. Amarin Secures Global Intellectual Property Rights for Lipid Programs
7. ActivBiotics Intellectual Property Assets, Including Drug Product Candidates, Sold for $3.5 Million
8. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
9. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
10. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
11. IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Rust removal is one of home maintenance's essential processes. Without ... To help rust contractors make it less expensive, My Cleaning ... it called Rusterizer. It announced that for this month, ... Cleaning Products explained that rust could damage items in two ... The first one, it said, happens when rust forms in ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 The ... by Global Cooling, Inc., Athens, OH, USA, won the ... by the International Society for Biological and Environmental Repositories ... award, given to one product annually, recognizes the company’s ... ultra-low temperature freezer. The award was presented to ...
(Date:5/16/2013)... New Zealand (PRWEB) May 16, 2013 In ... was invited to speak to doctors in China about ... Australia and NZ, this was her first trip to lecture ... Dr. Hart visited Guangzhou and Fuzhou, home to 12 and ... in China is very high at this point in time. ...
(Date:5/16/2013)... Kitware , a leading provider ... Phase II SBIR funding from the U.S. Department ... open-source, high performance computing (HPC) simulation and computation ... to select only the toolkits and applications needed ... analysis tasks. , Manufacturers increasingly rely on ...
Breaking Biology Technology:Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2
... SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) ... Hu, the Company,s Chief Operating Officer and,acting Chief Financial ... in New York on Wednesday, June 17, 2009, at ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) , ...
... SHANGHAI, June 16 /PRNewswire-Asia/ -- Sundia MediTech Company, a,Shanghai-based ... facility in Shanghai has passed the audit from a ... are praised,for providing good facilities and programs for the ... The inspection and audit took place in May. ...
... /PRNewswire-Asia/ -- Pharmaceutical company Pharmaxis,(ASX: PXS; Nasdaq: PXSL ... completed international Phase III trial of Bronchitol in patients,with cystic ... in Brest, France. , The results ... Dr Diana,Bilton of the Royal Brompton Hospital, London. , ...
Cached Biology Technology:Sundia's Animal Facility Passed Client and Government Inspection 2Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 2Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 3Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 4
(Date:5/16/2013)... MA -- Injectable nanoparticles developed at MIT may ... 1 diabetes to constantly monitor their blood-sugar levels ... were designed to sense glucose levels in the ... of insulin, thereby replacing the function of pancreatic ... Type 1 diabetes. Ultimately, this type of system ...
(Date:5/16/2013)... so many sports players and athletes choose to wear ... to be published in Psychological Science , a ... it may have to do with their testosterone levels. ... Farrelly of the University of Sunderland and colleagues, demonstrated ... a competitive task had higher testosterone levels than other ...
(Date:5/16/2013)... years old give unprecedented insight into the evolutionary ... most species-rich groups among the modern bony fishes. ... from the Division of Paleontology and Geobiology at ... Ludwig-Maximilians-Universitaet (LMU) in Munich / Germany have completed ... assign to the group of bony fishes that ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3High-testosterone competitors more likely to choose red 2Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3
... FAIRBANKS, AlaskaFor most northern indigenous people, the roughly 3 ... terrestrial subsistence resource, and while hunters and scientists alike ... caribou, their perceptions of the causes of change have ... natural resources based on their knowledge of how ecosystems ...
... YORK (FEBRUARY 13, 2008) The Wildlife Conservation Society ... 5,000 mile-long genetic corridor from Bhutan to Burma that ... The corridor, first announced at the United Nations on ... largest block of tiger habitat left on earth. ...
... MD ,FEB. 13, 2007 In an innovative program to ... scientists and parents, the American Society for Cell Biology ... Foundation will fund awards for child care during the ... Joan Goldberg. Goldberg said that the $16,000 ...
Cached Biology News:Seeking sustainability in a world of instability 2'Genetic corridors' are next step to saving tigers 2'Genetic corridors' are next step to saving tigers 3Cell biologists announce child-care grants for scientist-parents at annual meeting 2
... Ac-DEVD-CHO is an inhibitor ... The concentration of inhibitor ... activity must be determined ... Ten micromolar inhibitor is ...
TUNEL Apoptosis Detection Kit...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
homeo box D3, mRNA...
Biology Products: